Document is current
Any future updates will be listed below
-
Authors
Loesch, Douglas P. https://orcid.org/0000-0001-5716-4557
Garg, Manik https://orcid.org/0000-0003-0453-2058
Matelska, Dorota
Vitsios, Dimitrios https://orcid.org/0000-0002-8939-5445
Jiang, Xiao
Ritchie, Scott C. https://orcid.org/0000-0002-8454-9548
Sun, Benjamin B. https://orcid.org/0000-0001-6347-2281
Runz, Heiko https://orcid.org/0000-0002-2133-7345
Whelan, Christopher D. https://orcid.org/0000-0003-0308-5583
Holman, Rury R. https://orcid.org/0000-0002-1256-874X
Mentz, Robert J.
Moura, Filipe A.
Wiviott, Stephen D.
Sabatine, Marc S.
Udler, Miriam S. https://orcid.org/0000-0003-3824-9162
Gause-Nilsson, Ingrid A.
Petrovski, Slavé https://orcid.org/0000-0002-1527-961X
Oscarsson, Jan https://orcid.org/0000-0002-4573-517X
Nag, Abhishek
Paul, Dirk S. https://orcid.org/0000-0002-8230-0116
Inouye, Michael
- License Information
-
More Information
Article History
Received: 4 April 2024
Accepted: 22 January 2025
First Online: 3 March 2025
Competing interests
: D.P.L., M.G., D.M., D.V., X.J., I.A.G., S.P., J.O., A.N. and D.S.P. are employees of AstraZeneca and may hold AstraZeneca stock options. B.B.S. and H.R. are employees of Biogen and may hold stock options. C.D.W. is an employee of Janssen Pharmaceuticals, a Johnson & Johnson company, and may hold stock options. R.R.H. reports personal fees from Anji Pharmaceuticals, AstraZeneca and Novartis. R.J.M. received research support and honoraria from Abbott, American Regent, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Cytokinetics, Fast BioMedical, Gilead, Innolife, Eli Lilly, Medtronic, Medable, Merck, Novartis, Novo Nordisk, Pfizer, Pharmacosmos, Relypsa, Respicardia, Roche, Rocket Pharmaceuticals, Sanofi, Verily, Vifor, Windtree Therapeutics, and Zoll. M.I. is a trustee of the Public Health Genomics (PHG) Foundation, a member of the Scientific Advisory Board of Open Targets and has research collaborations with Nightingale Health and Pfizer which are unrelated to this study. F.A.M. received consulting fees from Janssen. S.D.W. received grants from Amgen, AstraZeneca, Daiichi Sankyo, Eisai, Janssen, Merck, and Pfizer, and consulting fees from AstraZeneca, Boston Clinical Research Institute, Icon Clinical, and Novo Nordisk. M.S.S. received research grant support through Brigham and Women’s Hospital from Abbott, Amgen, Anthos Therapeutics, AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo, Eisai, Intarcia, Ionis, Merck, Novartis, and Pfizer, and consulting for Althera, Amgen, Anthos Therapeutics, AstraZeneca, Beren Therapeutics, Boehringer Ingelheim, Bristol-Myers Squibb, Dr. Reddy’s Laboratories, Fibrogen, Intarcia, Merck, Moderna, Novo Nordisk, Precision BioSciences, and Silence Therapeutics. The remaining authors declare no competing interests.
